Search clinical trials for: Behavioral Effects

Total 131143 results

Ludwig-Maximilians - University of Munich
Heinrich-Heine University, Duesseldorf; University of Cologne; RWTH Aachen University and other collaborators

Unknown

Optimization of Acute Treatment in First Episode Schizophrenia

Schizophrenia, First-Episode

Germany
S. Andrea Hospital

Unknown

Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS Patients

Multiple Sclerosis

Italy
Radboud University Medical Center

Completed

Effects of Sublingual Immunotherapy on Grasspollen Allergy

Hayfever

Netherlands
Khon Kaen University

Completed

Pre-Emptive Analgesia Efficacy of Etoricoxib for Postoperative Pain

a Single-Dose of Etoricoxib | Post-Operative Morphine Consumption | Total Pain Relief Over 8 Hr(TOPAR8) | Post Transabdominal Hysterectomy

Thailand
UMC Utrecht
Dutch Kidney Foundation; Dianet Dialysis Centers

Completed

Effects of Daily Home Hemodialysis on Circulation, Mental Functions, and Quality of Life

End-Stage Renal Disease

Netherlands
Bangkok Metropolitan Administration Medical College...

Completed

Oral Versus Vaginal Misoprostol for Induction of Labor

Termed Pregnancy With Indications for Labor Induction.

Thailand
Royal Free and University College Medical School

Unknown

Effects of Long Term Macrolide Antibiotic Therapy in Patients With COPD

COPD

United Kingdom
Children's Hospital of Eastern Ontario

Completed

A Study of Two Versus Three Daily Injections in Children and Adolescents With Newly Diagnosed Type 1 Diabetes

Diabetes Mellitus, Type 1

Canada
Austin Health

Terminated

The Effect of Isoflurane or Sevoflurane on Kidney Function

Kidney Failure

Australia
Glostrup University Hospital, Copenhagen

Unknown

Hyaluronan Versus NaCl 20 Ml Versus Placebo in Knee Osteoarthritis

Osteoarthritis, Knee

Denmark
UMC Utrecht

Completed

Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Patients

Chronic Hepatitis C

Netherlands
Mylan Bertek Pharmaceuticals

Completed

A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.

Parkinson Disease
Mylan Bertek Pharmaceuticals

Completed

Long Term Safety and Efficacy of SC Apomorphine in Treatment of "Off" Episodes in Late-Stage Parkinson's Disease

Parkinson Disease

United States
Centers for Disease Control and Prevention
University of North Carolina

Completed

Using the Healthcare Visit to Improve Contraceptive Use

Pregnancy | Chlamydia

United States
Radboud University Medical Center
Dutch Dairy Organization (NZO)

Completed

The CARO Study - Bioefficacy of Beta-Carotene in Oil and in a Mixed Diet in Healthy Subjects

Healthy

Netherlands
Radboud University Medical Center
Dutch Dairy Organization (NZO)

Completed

The STOVITA Study - Bioefficacy of Beta-Carotene in Oil and in a Mixed Diet in Ileostomy Patients

Healthy | Ileostomy

Netherlands
Rafa Laboratories
Dr. Falk Pharma GmbH

Completed

Treatment of Gastro-Intestinal and/or Hepatic Graft Versus Host Disease With Budesonide in Patients Following Peripheral Blood Stem Cell Transplantation

Graft Vs Host Disease

Israel
University Hospital, Saarland
Hoffmann-La Roche

Unknown

Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA)

Hepatitis C, Chronic
Gustave Roussy, Cancer Campus, Grand Paris

Terminated

Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial Tract

Carcinoma, Transitional Cell

France
CollaGenex Pharmaceuticals

Completed

A Clinical Trial to Determine the Effects of 40 Mg Doxycycline Versus a Placebo Control for the Treatment of Rosacea

Rosacea
Wageningen Centre for Food Sciences

Completed

Effect of Betaine, Serine and Folic Acid on Vascular Function in Healthy Volunteers

Cardiovascular Diseases | Healthy

Netherlands
East Valley Hematology and Oncology Medical Group
Astex Pharmaceuticals, Inc.; Pharmatech Oncology; Mena, Raul, M.D.

Unknown

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Chronic Lymphocytic Leukemia

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detoxification - BBDVI - 19

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Combination Tablet Feasibility - 1

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Pharmacology Related to Addiction Treatment - 18

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Pharmacology Related to Addiction Treatment - 21

Opioid-Related Disorders

United States
French National Agency for Research on AIDS and...
Hoffmann-La Roche

Terminated

Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's Lymphoma

AIDS Related Lymphoma

France
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase X - 15

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase XII - 17

Opioid-Related Disorders

United States
University of British Columbia
Canadian Institutes of Health Research (CIHR)

Terminated

Effects of NIMV on the Health Status of Chronic Obstructive Pulmonary Disease (COPD )Patients

Chronic Obstructive Pulmonary Disease

Canada
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detox With Two Types of Treatment. BBD I - 10

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Methadone/Buprenorphine Cross-Over Study - 4

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Dosing Interval - 5

Opioid-Related Disorders

United States
French National Agency for Research on AIDS and...
Schering-Plough

Terminated

Structured Treatment Interruptions With or Without Pegylated Interferon Alpha for HIV-Infected Patients After Prolonged Viral Suppression

HIV Infections

France
Universitätsklinikum Hamburg-Eppendorf

Completed

Metyrapone as Additive Treatment in Major Depression

Major Depressive Disorder

Germany
Repligen Corporation

Completed

Synthetic Human Secretin in Children With Autism

Autism

United States
Makerere University
Ministry of Health, Uganda; Sanofi-Synthelabo

Unknown

Efficacy of Intrarectal Versus Intravenous Quinine for the Treatment of Childhood Cerebral Malaria

Cerebral Malaria

Uganda
Wageningen Centre for Food Sciences

Completed

Effect of Betaine and Folic Acid on Vascular Function in Healthy Humans

Cardiovascular Diseases | Healthy

Netherlands
Heidelberg University
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Rapamycin Use in Calcineurin Inhibitor (CNI)-Free Immunosuppression for Stabilization/Improvement of Renal Function After Heart Transplantation

Renal Failure | Heart Transplantation

Germany
Royal Brompton & Harefield NHS Foundation Trust
GlaxoSmithKline; CORDA, The Heart Charity

Unknown

Rosiglitazone Plaque Study

Vascular Diseases | Hypertension | Diabetes Mellitus, Type 2

United Kingdom
French National Agency for Research on AIDS and...
Schering-Plough

Terminated

Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non Responders

Hepatitis C, Chronic

France
Khon Kaen University
National Research Council of Thailand

Completed

Single Injection of Dexamethasone for Acute Bronchiolitis in Young Children

Bronchiolitis, Viral

Thailand
University of Oxford
Wyeth is now a wholly owned subsidiary of Pfizer; Pfizer

Completed

An Evaluation of the Effectiveness of a Simple Marketing Intervention in Changing Student Attitudes to Depression

Depression

United Kingdom
Connor, Kathryn M., M.D.
Forest Laboratories

Completed

Study of Escitalopram in the Treatment of Specific Phobia

Phobic Disorders

United States
Oregon Health and Science University

Completed

4% Intrauterine Lidocaine Infusion for Pain Management in First Trimester Abortions

Pain

United States
Otsuka America Pharmaceutical

Completed

Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

Raynaud's Disease

United States
Otsuka America Pharmaceutical

Completed

Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

Raynaud's Disease

United States
Oregon Health and Science University

Completed

Continuous Oral Contraceptives (COCs): Are Bleeding Patterns Dependent on the Hormones Given?

Breakthrough Bleeding

United States
University of Sydney
National Health and Medical Research Council, Australia; Sydney South West... and other collaborators

Unknown

Trial for the Treatment of Alcohol Dependence

Alcoholism

Australia

Search clinical trials for: Behavioral Effects

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations